Departamento de Biología Molecular, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León 64720, México.
Universidad Autónoma de Nuevo León, UANL, Facultad de Ciencias Biológicas, San Nicolás de los Garza, Nuevo León 66451, México.
Mol Med Rep. 2018 Apr;17(4):6150-6155. doi: 10.3892/mmr.2018.8626. Epub 2018 Feb 21.
The smallest product of the Duchenne muscular dystrophy gene, dystrophin (Dp)71, is ubiquitously expressed in nonmuscle tissues. We previously showed that Dp71 expression in hepatic cells is modulated in part by stimulating factor 1 (Sp1), stimulating protein 3 (Sp3), and yin yang 1 (YY1) transcription factors, and that the polyaromatic hydrocarbon, β-naphthoflavone (β‑NF), downregulates Dp71 expression. The aim of the present study was to determine whether β‑NF represses Dp71 expression by altering mRNA stability or its promoter activity. Reverse transcription‑quantitative polymerase chain reaction was used to measure half‑life mRNA levels in β‑NF‑treated cells exposed to actinomycin D, an inhibitor of transcription, for 0, 4, 8, 12 and 16 h. Transient transfections with a plasmid carrying the Dp71 basal promoter fused to luciferase reporter gene were carried out in control and β‑NF‑treated cells. Electrophoretic mobility shift assays (EMSAs) were performed with labeled probes, corresponding to Dp71 promoter sequences, and nuclear extracts of control and β‑NF‑treated cells. To the best of our knowledge, the results demonstrated for the first time that this negative regulation takes place at the promoter level rather than the mRNA stability level. Interestingly, using EMSAs, β‑NF reduced binding of YY1, Sp1, and Sp3 to the Dp71 promoter. It also suggests that β‑NF may modulate the expression of other genes regulated by these transcription factors. In conclusion, β‑NF represses Dp71 expression in hepatic cells by altering binding of YY1, Sp1, and Sp3 to the Dp71 promoter.
杜氏肌营养不良症基因的最小产物肌营养不良蛋白(Dp)71 在非肌肉组织中广泛表达。我们之前的研究表明,肝实质细胞中 Dp71 的表达受转录因子 Sp1、Sp3 和 YY1 的调节,多环芳烃β-萘黄酮(β-NF)下调 Dp71 的表达。本研究旨在确定 β-NF 是否通过改变 mRNA 稳定性或启动子活性来抑制 Dp71 的表达。用 β-NF 处理细胞后,用放线菌素 D(一种转录抑制剂)处理细胞 0、4、8、12 和 16 小时,用逆转录定量聚合酶链反应(RT-qPCR)测量半寿期 mRNA 水平。在对照和 β-NF 处理的细胞中进行了带有与荧光素酶报告基因融合的 Dp71 基础启动子的质粒的瞬时转染。用相应的 Dp71 启动子序列的标记探针进行电泳迁移率变动分析(EMSA),并对对照和 β-NF 处理的细胞的核提取物进行电泳迁移率变动分析(EMSA)。据我们所知,结果首次表明这种负调控发生在启动子水平而不是 mRNA 稳定性水平。有趣的是,通过 EMSA,β-NF 减少了 YY1、Sp1 和 Sp3 与 Dp71 启动子的结合。这也表明,β-NF 可能调节其他受这些转录因子调节的基因的表达。总之,β-NF 通过改变 YY1、Sp1 和 Sp3 与 Dp71 启动子的结合来抑制肝实质细胞中 Dp71 的表达。